VirTrial, a virtual care management platform for the clinical trial industry, announced Dec. 12 it has acquired telehealth provider SnapMD for an undisclosed amount.
SnapMD will continue to offer its virtual care solutions to providers and other healthcare organizations while operating as a subsidiary of VirTrial. Additionally, SnapMD's technology will be integrated into its buyer's platform to improve functionality and simplify the user experience as part of VirTrial's mission to streamline the clinical trial process for sponsors, sites and participants.
"We are extremely thrilled to join the VirTrial team and drive the evolution of telemedicine platforms in the clinical research industry," David Skibinski, CEO of SnapMD, said in the announcement. "This transaction will enable SnapMD to further its commitment to improve access to care, regardless of setting, through an industry-best telemedicine solution and unmatched breadth of services."
More articles on telehealth:
Ochsner becomes 1st provider partner of telemedicine startup Hims & Hers
Dartmouth Hitchcock extends telemedicine ICU program to local hospital
106 hospitals, health systems that launched telehealth services in 2019